The Hidden Conductors: How Hormones Shape the Human Mind

## Introduction

Long before neuroscience had the tools to image a thought, physicians already suspected that something moving invisibly through the blood could remake a person's mood, temperament, and sense of self. That something is hormones. Secreted by glands scattered from the brain to the gonads, these chemical messengers do far more than regulate metabolism, growth, and reproduction. They also wire and rewire the very brain circuits responsible for emotion, motivation, cognition, and social connection. To understand mental health without understanding endocrinology is to read only half the story.

This essay argues that hormones constitute one of the most fundamental, and most underappreciated, forces shaping human psychological life. It traces this influence across three dimensions: the body's internal stress-response machinery; the sweeping hormonal transitions that punctuate the human lifespan, from puberty through the reproductive years to andropause and menopause; and the subtler rhythms imposed by light, season, and the biological clock. Across all three, a common thread emerges — mental health is not simply a matter of thoughts and circumstances, but of biochemistry unfolding in time, differently in every body, and differently between the sexes.

## The Stress Axis: Cortisol as Master Regulator

At the center of the body's response to threat sits the hypothalamic-pituitary-adrenal (HPA) axis, a feedback loop in which the hypothalamus releases corticotropin-releasing hormone, the pituitary responds with adrenocorticotropic hormone, and the adrenal cortex finally releases cortisol into the bloodstream. In short bursts, cortisol is protective, sharpening attention and mobilizing energy. The trouble begins when the system does not shut off. Chronic stress keeps the HPA axis switched on, and the resulting oversupply of cortisol reshapes the brain itself, producing dendritic atrophy, suppressed neurogenesis, and volumetric shrinkage in the hippocampus, a region central to memory and emotional regulation (Lei et al., 2025). This cascade is compounded by neuroinflammation and oxidative stress, which together aggravate depressive symptoms and impair the very negative-feedback loop that should bring cortisol back down (Lei et al., 2025).

The clinical evidence for this pathway is extensive. Elevated or dysregulated cortisol — whether chronically high or, in some cases, paradoxically blunted — has been consistently linked to major depressive disorder, anxiety disorders, bipolar disorder, and psychosis (George et al., 2025). In depression specifically, the classic pattern involves a flattened diurnal cortisol rhythm and an exaggerated cortisol awakening response, changes that parallel, in milder form, what is seen in Cushing's syndrome, a disease of cortisol excess in which the majority of patients develop clinical depression (George et al., 2025). Cortisol does not act alone: it suppresses brain-derived neurotrophic factor, a protein essential for neuronal survival, and it interferes with serotonin transport and tryptophan availability, offering a direct biochemical bridge between chronic stress and the neurotransmitter systems targeted by antidepressant medication (George et al., 2025). Recent Mendelian randomization work using genetic variants that influence morning cortisol levels has even provided evidence of a causal, not merely correlational, relationship between cortisol and anxiety (George et al., 2025). In short, the stress axis is not a metaphor for psychological pressure; it is a literal, measurable pathway by which experience becomes biology, and biology becomes mood.

## The Rhythms of Sex Hormones: The Menstrual Cycle and Premenstrual Dysphoric Disorder

If cortisol illustrates how hormones respond to the environment, estrogen and progesterone illustrate how hormones generate their own internal weather. Across the menstrual cycle, estradiol and progesterone rise and fall in a predictable pattern, and for a meaningful minority of women, this fluctuation destabilizes mood dramatically. Premenstrual dysphoric disorder (PMDD), which the DSM-5 formally recognized as a depressive disorder in 2013, affects an estimated 3–8% of reproductive-age women, producing irritability, mood lability, and depressed mood concentrated in the late luteal phase (Del Casale et al., 2020, as cited in the broader literature on menstrual-cycle cognition).

What makes PMDD scientifically striking is that it is not caused by abnormal hormone levels. Women with PMDD have essentially the same estradiol and progesterone concentrations as women without it; what differs is their brain's sensitivity to entirely normal hormonal fluctuation. The leading explanation centers on allopregnanolone (ALLO), a metabolite of progesterone that acts as a positive modulator of GABA-A receptors, the brain's primary inhibitory, calming system. In women with PMDD, the same physiological levels of ALLO appear to trigger paradoxical anxiety and mood disturbance rather than calm, and functional imaging shows heightened activity in emotion-processing regions such as the amygdala and parahippocampal gyrus during the late-luteal phase in these women (Bixo et al., 2023). This altered-sensitivity model is powerfully confirmed by a classic experimental paradigm: when euthymic women with a history of PMDD have their estrogen and progesterone pharmacologically suppressed and then "added back," their mood symptoms recur, while women without a PMDD history remain stable under the identical hormonal manipulation (Schmidt et al., 1998, as reviewed in Frieler et al., 2025). The lesson is important and often missed in popular discussion of "hormonal" mood swings: it is not the hormone level that matters, but the individual brain's response to it.

## Puberty: The Hormonal Storm and the Origin of the Sex Gap in Depression

Adolescence supplies perhaps the clearest natural experiment in how hormones sculpt mental health risk. Before puberty, rates of depression and anxiety in boys and girls are roughly similar; within a few years of pubertal onset, girls become roughly twice as likely as boys to develop depression, a gap that then persists across the entire reproductive lifespan (Kessler et al., 1993, as cited in Vijayakumar's group; see also Lei et al., 2025 for parallel discussion of stress-sensitive periods). A systematic review of 55 population-based studies found consistent, if not fully causal, associations between rising testosterone and estradiol levels and the emergence of specific mental health problems in children and adolescents, alongside less consistent findings for adrenal androgens such as DHEA (Luo et al., 2024).

Several mechanisms have been proposed to explain why the female brain appears more vulnerable during this window. One is timing: girls typically enter puberty twelve to eighteen months earlier than boys, and earlier pubertal timing specifically is associated with elevated depression risk in girls, suggesting a sensitive developmental window in which the brain is unusually reactive to sex steroids (Vijayakumar, Youssef, & Allen, 2021, as cited in Luo et al., 2024). Another is structural: estrogen and progesterone receptors are distributed asymmetrically across emotion-relevant brain circuitry, and the size of limbic structures such as the hippocampus appears to mediate the relationship between early testosterone exposure and depressive symptoms (Ellis, Fernandes, & Simmons, as cited in Luo et al., 2024). A third, harder to disentangle experimentally, is social: the same physical changes that mark hormonal maturation also alter how peers, and sometimes predators, respond to a maturing adolescent, adding a psychosocial layer on top of the neuroendocrine one (Skoog, Bayram Özdemir, & Stattin, as cited in Luo et al., 2024). What is not in serious dispute is the basic fact that puberty is a hormonally driven turning point in the epidemiology of mental illness, and that its effects diverge sharply along sex lines.

## Reproductive Transitions: Pregnancy, Postpartum, and Menopause

If puberty opens the reproductive hormonal era, childbirth and menopause mark its most turbulent internal transitions. Postpartum depression (PPD) affects an estimated 20% of new mothers in the United States (Reddy, Mbilinyi, & Estes, 2023) and offers one of the clearest illustrations of hormone withdrawal, rather than hormone excess, as a psychiatric trigger. During pregnancy, progesterone and its neurosteroid metabolite allopregnanolone rise to extraordinary levels; within hours of delivery, both collapse. For most women this "neurosteroid withdrawal" is uneventful, but for a hormone-sensitive subgroup it appears to precipitate a major depressive episode (Reddy et al., 2023).

The clinical payoff of this mechanistic insight has been substantial. Brexanolone, an intravenous formulation of allopregnanolone, became the first FDA-approved medication specifically for postpartum depression in 2019, acting as a positive allosteric modulator of GABA-A receptors to relieve symptoms within about sixty hours, dramatically faster than conventional antidepressants (Reddy et al., 2023). An oral neurosteroid, zuranolone, followed with similar logic (Reddy et al., 2023). As one Johns Hopkins reproductive psychiatrist has put it, the postpartum period is one of several life stages — alongside the premenstrual window and perimenopause — in which hormonal fluctuation itself, rather than any single hormone's absolute level, becomes a trigger for psychiatric vulnerability (Standeven, as cited in Johns Hopkins Medicine, 2023).

Menopause extends this pattern into midlife. As estradiol production declines and becomes erratic during the perimenopausal transition, many women experience new or recurrent depressive symptoms, mediated by many of the same neurosteroid and serotonergic pathways implicated in PMDD and PPD (Reddy et al., 2023). The consistent theme across all three reproductive transitions is that the nervous system's stability depends not on hormones staying at any fixed level, but on the brain's capacity to adapt smoothly as those levels change — a capacity that itself appears to vary meaningfully between individuals.

## Testosterone and the Question of "Andropause"

Men experience a hormonal transition of their own, though a far more gradual one. Testosterone declines by roughly 1–1.4% per year after midlife, and by age seventy-five, mean levels have fallen by about a third, with more than a quarter of men in this age group meeting laboratory criteria for hypogonadism (Seidman, 2007, as cited in reviews of andropausal depression). The resulting cluster of symptoms — fatigue, irritability, low mood, and reduced motivation — has been popularly labeled "andropause" or "male menopause," and one clinical sample found depressive disorders in roughly 42% of men attending an andrology clinic (Sato et al., 2007, as cited in reviews of andropause).

Scientific opinion on this syndrome, however, remains notably more cautious than the popular narrative. Reviews of the evidence have repeatedly found it difficult to establish a clean correlation between testosterone levels and depressive symptoms in aging men, and placebo-controlled trials of testosterone replacement for depression have yielded inconsistent results (Seidman, 2007, as cited in Amanatkar et al., 2014). Unlike the abrupt hormonal cliff of menopause, the male decline is gradual enough that it is genuinely difficult to separate its direct neurobiological effects from the psychosocial dimensions of aging itself. This does not mean testosterone is irrelevant to male mood; it means the relationship is more entangled with life stage, health status, and social context than a simple "low T causes depression" narrative suggests.

## The Social Hormone: Oxytocin and the Buffering of Stress

Not every hormonally mediated mental health effect concerns distress; some concern connection. Oxytocin, produced in the hypothalamus and released both centrally and peripherally, plays a central role in social bonding, parental attachment, trust, and empathy (Erdogan et al., 2022). Critically, oxytocin also modulates the HPA axis directly, dampening cortisol release and reducing anxiety in response to acute stress, particularly in the presence of social support (Cochran et al., 2013, as cited in reviews of oxytocin and depression). This gives oxytocin a distinctive role among the hormones discussed here: rather than driving distress, it appears to buffer against it, and disruption of the oxytocin system in early life, through neglect or trauma, has been linked to elevated later risk of anxiety, depression, and other stress-related psychiatric conditions (Chen, Panagiotidis, & Lin, 2023, as cited in reviews of oxytocin and early-life stress). The therapeutic implication, still being tested in clinical trials, is that oxytocin or oxytocin-system modulation could eventually complement more traditional stress- and mood-focused treatments (Erdogan et al., 2022).

## Thyroid Hormones: The Quiet Regulator of Mood

Thyroid hormone rarely enters popular conversations about mood, yet it is essential for brain maturation, mitochondrial function, and myelination throughout life, and its disruption produces some of the most reliably documented hormone-mood links in psychiatry (Psych Scene Hub, 2026). Both hypothyroidism and, less commonly, hyperthyroidism are associated with depressive and anxiety symptoms, and population-based cohort studies, including a large UK Biobank analysis, have confirmed a robust prospective association between thyroid disease and later depression and anxiety diagnoses. Subclinical hypothyroidism, in which standard blood tests may look only mildly abnormal, has itself been linked to depression in systematic reviews and meta-analyses (Loh, Lim, Yee, & Loh, as cited in thyroid-psychiatry literature). The clinical significance is practical as much as theoretical: because thyroid dysfunction is common, treatable, and easily tested for, it represents one of the few hormone-mood links where correcting the underlying endocrine problem can directly resolve psychiatric symptoms that might otherwise be misattributed purely to "stress" or personality.

## Environmental Rhythms: Circadian, Seasonal, and Lunar Influences

The hormonal story does not end inside the body; it is entrained by the external world. Melatonin, secreted by the pineal gland in a tight nightly rhythm, functions as the body's internal marker of darkness, and light exposure is the single most powerful signal that resets it (Auger & Emens, 2016, as cited in melatonin-circadian reviews). Disruption of this rhythm has widespread consequences for mental health: circadian misalignment has been linked to depression, and seasonal affective disorder, in which mood reliably worsens during the shorter, darker days of winter, is understood partly through season-dependent abnormalities in how light suppresses melatonin secretion (Lewy et al., as cited in seasonal affective disorder literature). Light therapy, the first-line treatment for seasonal depression, works precisely by correcting this circadian and melatonergic disturbance.

The question of lunar influence is more delicate, and honesty requires separating folklore from evidence. Centuries of belief that the full moon disturbs sleep and mood have mostly failed rigorous scientific testing, and large epidemiological studies have generally found no reliable lunar effect on psychiatric hospital admissions or crisis-line calls. Yet one especially careful study deserves mention precisely because of its methodological rigor: Cajochen et al. (2013) retrospectively analyzed sleep recorded under strictly controlled laboratory conditions, where participants and researchers were both unaware that lunar phase would later be examined, eliminating the usual confounds of moonlight exposure or subjective belief. They found that around the full moon, deep slow-wave EEG activity during sleep fell by about 30%, time to fall asleep increased, total sleep duration shortened, and evening melatonin secretion was measurably lower (Cajochen et al., 2013). This remains, more than a decade later, one of the only findings of a lunar effect on human physiology to survive such stringent controls, and it has not been consistently replicated at this scale elsewhere. The fair conclusion is not that "the moon controls your mind," but that under sufficiently careful measurement, a subtle lunar influence on sleep architecture and melatonin appears real, while its downstream psychological significance remains genuinely open and should not be overstated.

## Conclusion

Taken together, the evidence surveyed here supports a claim stronger than the common observation that "hormones affect mood." Hormones function as an integrated regulatory layer, operating alongside and often beneath conscious awareness, that shapes vulnerability to depression and anxiety across the entire human lifespan. Cortisol translates chronic stress into structural brain change; estrogen and progesterone generate an internal monthly weather system to which some brains are more reactive than others; puberty recalibrates this system in a way that disproportionately burdens girls and women; pregnancy, childbirth, and menopause each represent a hormonal cliff that a meaningful minority of women cannot descend smoothly; testosterone's decline complicates male aging in ways science has not yet fully resolved; oxytocin offers a biological counterweight to stress through social connection; thyroid hormone quietly underwrites the basic biochemistry of mood; and the external rhythms of light and, more tentatively, the lunar cycle entrain the endocrine clock from outside the body altogether.

None of this reduces mental health to biochemistry alone; psychosocial context, life history, and individual meaning-making remain indispensable to understanding any person's psychological experience. But an account of mental health that ignores the endocrine system is missing one of its most fundamental mechanisms. Recognizing hormones as a genuine axis of psychological vulnerability, distinct from but interacting with life circumstance, opens the door to more precise, and often more compassionate, understanding of why mood can shift so profoundly across a life, a month, or even a season — and to treatments, from neurosteroid therapies to light exposure, that work by restoring the body's own regulatory rhythms rather than overriding them.

---

## References

Bixo, M., Ekberg, K., Poromaa, I. S., Hirschberg, A. L., Jonasson, A. F., Andréen, L., Timby, E., Wulff, M., Ehrenborg, A., & Bäckström, T. (2023). Emotion-induced brain activation across the menstrual cycle in individuals with premenstrual dysphoric disorder and associations to serum levels of progesterone-derived neurosteroids. Translational Psychiatry, 13, Article 96. https://doi.org/10.1038/s41398-023-02424-3

Cajochen, C., Altanay-Ekici, S., Münch, M., Frey, S., Knoblauch, V., & Wirz-Justice, A. (2013). Evidence that the lunar cycle influences human sleep. Current Biology, 23(15), 1485–1488. https://doi.org/10.1016/j.cub.2013.06.029

George, M. Y., Abdel Mageed, S. S., Mansour, D. E., … & Fawzi, S. F. (2025). The cortisol axis and psychiatric disorders: An updated review. Pharmacological Reports, 77(6), 1573–1599. https://doi.org/10.1007/s43440-025-00782-x

Johns Hopkins Medicine. (2023, February 8). Adult inpatient brexanolone service addresses postpartum depression. https://www.hopkinsmedicine.org/news/articles/2023/02/adult-inpatient-brexanolone-service-addresses-postpartum-depression

Lei, A. A., Phang, V. W. X., Lee, Y. Z., Kow, A. S. F., Tham, C. L., Ho, Y.-C., & Lee, M. T. (2025). Chronic stress-associated depressive disorders: The impact of HPA axis dysregulation and neuroinflammation on the hippocampus—A mini review. International Journal of Molecular Sciences, 26(7), Article 2940. https://doi.org/10.3390/ijms26072940

Luo, D., Dashti, S. G., Sawyer, S. M., & Vijayakumar, N. (2024). Pubertal hormones and mental health problems in children and adolescents: A systematic review of population-based studies. eClinicalMedicine, 76, Article 102828. https://doi.org/10.1016/j.eclinm.2024.102828

Psych Scene Hub. (2026). Thyroid and mental health: Role of thyroid gland in depression, anxiety and psychosis? https://psychscenehub.com/psychinsights/thyroid-gland-and-psychiatry/

Reddy, D. S., Mbilinyi, R. H., & Estes, E. (2023). Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: A landmark journey from concept to clinic in neurosteroid replacement therapy. Psychopharmacology. https://doi.org/10.1007/s00213-023-06427-2

Note on sources with incomplete author retrieval: A small number of supporting points (male hypogonadism/"andropause" prevalence and symptom data; oxytocin's stress-buffering and early-life-stress literature; menstrual-cycle cognition data; thyroid–depression cohort findings) are drawn from peer-reviewed reviews identified during research for this essay, but this draft was not able to confirm complete author lists for every such source within the available search results. If you intend to submit or publish this essay, I'd recommend verifying and completing those specific reference entries (e.g., via PubMed or the publishing journal's website) before final submission — I'm glad to help track down the exact citations if you'd like.